Dawood Sayed, MD
Professor of Anesthesiology and Pain Medicine and Division Chief of Pain Medicine at the University of Kansas Medical Center

Dr. Dawood Sayed is a professor of anesthesiology and pain medicine and division chief of pain medicine at the University of Kansas Medical Center. He serves as director of the Multidisciplinary Pain Medicine Fellowship and leads the Interventional Pain Program within the Comprehensive Spine Center.

Dr. Sayed is a co-founder and first president of the American Society of Pain and Neuroscience (ASPN) and currently serves as vice chairman of ASPN and the International Society of Pain and Neuroscience (ISPN). He is also an active leader in the North American Neuromodulation Society (NANS), contributing to the Advocacy, Policy, and Education Committees and serving as the NANS Alternate Delegate for CPT to the American Medical Association since 2017. Through these roles, he helps shape clinical standards, education, and reimbursement policy in neuromodulation and interventional pain medicine.

Dr. Sayed completed his residency in anesthesiology at the University of Kansas, followed by a pain medicine fellowship at Weill Cornell Medicine (tri-institutional program). He is a highly sought-after speaker, delivering national and international lectures for organizations including ASIPP, NANS, and ASRA on advanced interventional and neuromodulation techniques.

Clinically, Dr. Sayed specializes in complex spine and nerve disorders, with expertise spanning spinal cord stimulation, peripheral nerve stimulation, intrathecal drug delivery, vertebral augmentation, spinal tumor ablation, and cancer-related pain management. His work emphasizes minimally invasive, technology-enabled solutions to improve patient outcomes. An accomplished academic and innovator, Dr. Sayed has authored over 100 peer-reviewed publications and multiple textbooks focused on neuromodulation, interventional spine care, and oncologic pain. He is involved in advancing next-generation therapies, including adaptive and AI-driven neuromodulation platforms, and collaborates with industry to translate novel concepts into clinical practice.